Staphylococcus aureus menD and hemB mutants are as infective as the parent strains, but the menadione biosynthetic mutant persists within the kidney

Journal of Infectious Diseases

Volumn 187, Issue 10, 2003, Pages 1654-1661

  Bates, Donna M ^a   Von Eiff, Christof ^d   McNamara, Peter J ^a   Peters, Georg ^d   Yeaman, Michael R ^b,c   Bayer, Arnold S ^b,c   Proctor, Richard A ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

^c Research and Education Institute   (United States)

^d INST OF REPRO MED OF THE UNIV   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

OXACILLIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL ENDOCARDITIS; BACTERIAL GENE; BACTERIAL MUTATION; BACTERIAL VIRULENCE; CONTROLLED STUDY; HEMB GENE; KIDNEY; MEND GENE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PERSISTENT INFECTION; PRIORITY JOURNAL; RABBIT; SPLEEN; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STRAIN DIFFERENCE;

ANIMALS; BLOOD PROTEINS; DISEASE MODELS, ANIMAL; DRUG RESISTANCE, BACTERIAL; ENDOCARDITIS, BACTERIAL; FEMALE; GENES, BACTERIAL; KIDNEY; MALE; MICROBIAL SENSITIVITY TESTS; MUTATION; OXACILLIN; PENICILLINS; RABBITS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TIME FACTORS; VITAMIN K 3;

EID: 0038583506     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/374642     Document Type: Article

References (40)

1. Proctor RA, van Langevelde P, Kristjansson M, Maslow JN, Arbeit RD. Persistent and relapsing infections associated with small-colony variants of Staphylococcus aureus. Clin Infect Dis 1995; 20:95-102.
2. Proctor RA. Bacterial energetics and antimicrobial resistance. Drug Resist Updat 1998; 1:227-35.
3. Proctor RA. Respiration and small colony variants of Staphylococcal aureus. In: Fischetti V, Novick R, Ferretti J, Portnoy D, Rood J, eds. Gram-positive pathogens: staphylococci. Washington, DC: American Society for Microbiology Press, 2000:345-50.
4. Kahl B, Herrmann M, Everding AS, et al. Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis. J Infect Dis 1998; 177:1023-9.
5. Kahl BC, Duebbers A, Lubritz G, et al. Persistence of small colony variants (SCV) and/or normal S. aureus in respiratory secretions of cystic fibrosis (CF) patients: results of a 6 year prospective study [abstract D-41]. In: Program and abstracts of the 101st general meeting of the American Society for Microbiology (Orlando). Washington, DC: American Society for Microbiology, 2001:283.
6. von Eiff C, Bettin D, Proctor RA, et al. Recovery of small colony variants of Staphylococcus aureus following gentamicin bead placement for osteomyelitis. Clin Infect Dis 1997; 25:1250-1.
7. von Eiff C, Vaudaux P, Kahl BC, et al. Bloodstream infections caused by small-colony variants of coagulase negative staphylococci following pacemaker implantation. Clin Infect Dis 1999; 29:932-4.
8. Proctor RA, Bates DM, McNamara PJ. Electron transport-deficient Staphylococcus aureus small-colony variants as emerging pathogens. In: Craig W, ed. Emerging infections. Vol 5. Washington, DC: American Society for Microbiology Press, 2001:95-110.
9. Acar JF, Goldstein FN, Lagrange P. Human infections caused by thiamine- or menadione-requiring Staphylococcus aureus. J Clin Microbiol 1978; 8:142-7.
10. Baumert N, von Eiff C, Schaaff F, Peters G, Proctor RA, Sahl H-G. Physiology and antibiotic susceptibility of Staphylococcus aureus small colony variants. Microb Drug Resist 2002; 8:253-60.
11. von Eiff C, Heilmann C, Proctor RA, Woltz C, Peters G, Götz F. A site directed Staphylococcus aureus hemB mutant is a small colony variant which persists intracellutarly. J Bacteriol 1997; 179:4706-12.
12. McNamara PJ, Milligan-Monroe KC, Khalili S, Proctor RA. Identification, cloning, and initial characterization of rot, a locus encoding a repressor of extracellular toxins in Staphylococcus aureus. J Bacteriol 2000; 182:3197-203.
13. Byeon WH, Weisblum B. Replication genes of plasmid pE194-cop and repF: transcripts and encoded proteins. J Bacteriol 1990; 172:5892-900.
14. Janzon L, Arvidson S. The role of the delta-lysin gene (hld) in the regulation of virulence genes by the accessory gene regulator (agr) in Staphylococcus aureus. EMBO J 1990; 9:1391-9.
15. Kraemer GR, Iandolo JJ. High-frequency transformation of Staphylococcus aureus by electroporation. Curr Microbiol 1990; 21:373-6.
16. Dyer DW, Iandolo JJ. Rapid isolation of DNA from Staphylococcus aureus. Appl Environ Microbiol 1983; 46:283-5.
17. Bayer AS, Cheng D, Yeaman MR, et al. In vitro resistance to thrombin-induced platelet microbicial protein among clinical bacteremic isolates of Staphylococcus aureus correlates with an endovascular infection source. Antimicrob Agents Chemother 1998; 42:3169-72.
18. Wu T, Yeaman MR, Bayer AS. In vitro resistance to platelet microbicidal protein correlates with endocarditis source among bacteremic staphylococcal and streptococcal isolates. Antimicrob Agents Chemother 1994; 38:729-32.
19. Bayer AS, Ramos MD, Menzies BE, Yeaman MR, Shen AJ, Cheung AL. Hyperproduction of alpha-toxin by Staphylococcus aureus results in paradoxically reduced virulence in experimental endocarditis: a host defense role for platelet microbicidal proteins. Infect Immun 1997; 65: 4652-60.
20. Egert J, Carrizosa J, Kaye D, Kobasa WD. Comparison of methicillin, nafcillin, and oxacillin in therapy of Staphylococcus aureus endocarditis in rabbits. J Lab Clin Med 1977; 89:1262-8.
21. Cars O, Henning C, Holm SE. Penetration of ampicillin and dicloxacillin into tissue cage fluid in rabbits: relation to serum and tissue protein binding. Scand J Infect Dis 1981; 13:69-74.
22. Cars O. Tissue distribution of beta-lactam antibiotics: experimental studies in rabbits. Scand J Infect Dis Suppl 1981; 27:1-48.
23. Craven N, Anderson JC. Antibiotic activity against intraleukocytic Staphylococcus aureus in vitro and in experimental mastitis in mice. Am J Vet Res 1983; 44:709-12.
24. Roesler J, Hockertz S, Vogt B, Lohmann-Matthes ML. Staphylococci surviving intracellularly in phagocytes from patients suffering from chronic granulomatous disease are killed in vitro by antibiotics encapsulated in liposomes. J Clin Invest 1991; 88:1224-9.
25. Frank MO, Sullivan GW, Carper HT, Mandell GL. In vitro demonstration of transport and delivery of antibiotics by polymorphonuclear leukocytes. Antimicrob Agents Chemother 1992; 36:2584-8.
26. Seifert H, von Eiff C, Fatkenheuer G. Fatal case due to methicillin-resistant Staphylococcus aureus small colony variants in an AIDS patient. Emerg Infect Dis 1999; 5:450-3.
27. Abele-Horn M, Schupfner B, Emmerling P, Waldner H, Goring H. Persistent wound infection after herniotomy associated with small-colony variants of Staphylococcus aureus. Infection 2000; 28:53-4.
28. Spearman P, Lakey D, Jotte S, Chernowitz A, Claycomb S, Stratton C. Sternoclavicular joint septic arthritis with small-colony variant Staphylococcus aureus. Diagn Microbiol Infect Dis 1996; 26:13-15.
29. Salgado DR, Pinto M, Bozza FA, Sampaio J, Leite JP. Outbreak with small colony variants of methicillin-resistant Staphylococcus aureus in an ICU [abstract K-1226]. In: Program and abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy (Chicago). Washington, DC: American Society for Microbiology, 2001:416.
30. Balwit JM, van Langevelde P, Vann JM, Proctor RA. Gentamicin-resistant menadione and hemin auxotrophic Staphylococcus aureus persist within cultured endothelial cells. J Infect Dis 1994; 170:1033-7.
31. Vann JM, Proctor RA. Cytotoxic effects of ingested Staphylococcus aureus on bovine endothelial cells: role of S. aureus α-hemolysin. Microbial Pathogenesis 1988; 4:443-53.
32. Koo S-P, Bayer AS, Sahl H-G, Proctor RA, Yeaman MR. Staphylocidal action of thrombin-induced platelet microbicidal protein (tPMP) is not solely dependent on transmembrane potential (ΔΨ). Infect Immun 1996; 64:1070-4.
33. Vaudaux P, Francois P, Bisognano C, et al. Increased expression of clumping factor and fibronectin-binding proteins by small colony variants of Staphylococcus aureus. Infect Immun 2002; 70:5428-37.
34. Moreillon P, Entenza JM, Francioli P, et al. Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infect Immun 1995; 63:4738-43.
35. Que YA, Francois P, Haefliger JA, Entenza JM, Vaudaux P, Moreillon P. Reassessing the role of Staphylococcus aureus clumping factor and fibronectin-binding protein by expression in Lactococcus lactis. Infect Immun 2001; 69:6296-302.
36. Kuypers JM, Proctor RA. A fibronectin low-binding mutant of Staphylococcus aureus shows reduced adherence to traumatized rat heart valves. Infect Immun 1989; 57:2306-12.
37. Padmanaban G, Venkateswar V, Rangarajan PN. Haem as a multifunctional regulator. Trends Biochem Sci 1989; 14:492-6.
38. Dhawan VK, Bayer AS, Yeaman MR. Thrombin-induced platelet microbicidal protein susceptibility phenotype influences the outcome of oxacillin prophylaxis and therapy of experimental Staphylococcus aureus endocarditis. Antimicrob Agents Chemother 2000; 44:3206-9.
39. Shearer MJ, McCarthy PT, Crampton OE, Mattock MB. The assessment of human vitamin K status from tissue measurements. In: Suttie JW, ed. Current advances in vitamin K research. New York: Elsevier, 1987: 437-52.
40. Jonsson I-M, von Eiff C, Proctor RA, Peters G, Ryden C, Tarkowski A. Virulence of a hemB mutant displaying the phenotype of a Staphylococcus aureus small colony variant in a murine model of septic arthritis. Microb Pathog 2003; 34:73-9.